{
  "(0, 0, 1)": "Type",
  "(0, 1, 1)": "Aktiengesellschaft",
  "(1, 0, 1)": "Traded as",
  "(1, 1, 1)": "FWB: SAZ",
  "(2, 0, 1)": "Industry",
  "(2, 1, 1)": "Pharmaceuticals",
  "(3, 0, 1)": "Founded",
  "(3, 1, 1)": "Dresden, 1895",
  "(4, 0, 1)": "Headquarters",
  "(4, 1, 1)": "Bad Vilbel, Germany",
  "(5, 0, 1)": "Key people",
  "(5, 1, 1)": "Peter Goldschmidt CEO",
  "(5, 2, 1)": "Günter von Au (Chairman of the supervisory board)",
  "(6, 0, 1)": "Products",
  "(6, 1, 1)": "Generic and over-the-counter drugs",
  "(7, 0, 1)": "Revenue",
  "(7, 1, 1)": "€2.33 billion (2018)",
  "(8, 0, 1)": "Operating income",
  "(8, 1, 1)": "€378.1 million (2018)",
  "(9, 0, 1)": "Net income",
  "(9, 1, 1)": "€306.9 million (2018)",
  "(10, 0, 1)": "Total assets",
  "(10, 1, 1)": "€3.335 billion (end 2014)",
  "(11, 0, 1)": "Total equity",
  "(11, 1, 1)": "€903.3 million (end 2014)",
  "(12, 0, 1)": "Number of employees",
  "(12, 1, 1)": "10,416 (FTE, average 2018)",
  "(13, 0, 1)": "Website",
  "(13, 1, 1)": "www.stada.com"
}